Published in Immunotherapy Weekly, April 14th, 2004
The drug, cyclophosphamide, is given at such high doses that it destroys most or all of a patient's disease-fighting immune cells.
However, the stem cells within the patient's bone marrow survive the drug's onslaught, the doctors say, and then are stimulated with other drugs to rebuild the immune system from scratch, but without the bad triggers that caused the body to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2004-04-14)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.